R

Repligen Corp
D

RGEN

121.670
USD
-0.20
(-0.16%)
مغلق
حجم التداول
42,261
الربح لكل سهم
2
العائد الربحي
-
P/E
-290
حجم السوق
6,835,797,777
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
A
ARWR
-0.520
(-3.20%)
15.740 USD
BMRN
BMRN
-0.765
(-1.28%)
59.010 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
N
NTLA
0.830
(6.50%)
13.595 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
S
SRPT
-0.970
(-7.53%)
11.910 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Repligen Corp

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.